Lijun International Pharmaceutical Holding Co Ltd ($2005) - buy or sell? Stock discussion, ideas, forum

Lijun International Pharmaceutical Holding Co Ltd

Lijun International Pharmaceutical (Holding) Co., Ltd.

Industry: Pharmaceuticals

Ticker	Exchange	ISIN	Name
$2005	HKEx Main Board	KYG548821324	Code: 2005

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 2005 stock

Share your investment idea or question on Lijun International Pharmaceutical Holding Co Ltd stock:

Latest twits on Lijun International Pharmaceutical Holding Co Ltd (2005)

No twits yet. Be the first to post!

Have a question about 2005? Ask and other investors will be eager to help you.

Have an idea about 2005? Share it with other investors.

Lijun International Pharmaceutical Holding Co Ltd news

30/03/2016 Lijun International Pharmaceutical Holding Co Ltd CAPEX dropped on 49.8% in 2015 while Revenue increased on 6.2%

Lijun International Pharmaceutical Holding Co Ltd stock price chart

Lijun International Pharmaceutical Holding Co Ltd financials

mln.	FY2010	FY2011	FY2012

Revenue	1,972	2,155	2,431
EBITDA	428.6	133.9	523.8
Net income	260.6	-41.401	281.0
CAPEX	188.7	419.8	407.4
Debt	433.1	416.6	828.5
Cash	598.9	258.0	411.8

Lijun International Pharmaceutical Holding Co Ltd news

30/03/2016 Lijun International Pharmaceutical Holding Co Ltd CAPEX dropped on 49.8% in 2015 while Revenue increased on 6.2%

About Lijun International Pharmaceutical Holding Co Ltd

Lijun International Pharmaceutical (Holding) Co., Ltd. researches, develops, manufactures, and sells a wide range of pharmaceutical products.